The BCR has guided researchers to explore protocol options and treatment outcomes for multiple RT modalities, and has also prompted researchers to introduce more sensitive and accurate detection devices (such as PSMA-PET), which significantly enhanced the ability to localize PCa recurrence. This evidence concerns the gene BCR and posterior cortical atrophy.